NCT00568334View on ClinicalTrials.gov

Study of Two Formulations of GSK Biologicals' Varicella Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

November 1, 2007

Primary Completion Date

March 18, 2008

Study Completion Date

April 29, 2008

Conditions
Varicella
Interventions
BIOLOGICAL

Varilrix (inactivated varicella vaccine)

subcutaneously injection

Trial Locations (13)

1032

GSK Investigational Site, Budapest

1040

GSK Investigational Site, Budapest

1097

GSK Investigational Site, Budapest

1121

GSK Investigational Site, Budapest

3524

GSK Investigational Site, Miskolc

3528

GSK Investigational Site, Miskolc

3543

GSK Investigational Site, Miskolc

6723

GSK Investigational Site, Szeged

6792

GSK Investigational Site, Zsombó

6795

GSK Investigational Site, Bordány

9024

GSK Investigational Site, Győr

547 01

GSK Investigational Site, Náchod

532 03

GSK Investigational Site, Pardubice

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY